Company: PMVP
Filing Date: 2025-05-09
Form Type: 10-Q
Source: 0000950170-25-067513
Chunk: 10

Company: PMV Pharmaceuticals, Inc.
Filing Date: 2025-05-09
Form: 10-Q
Item: Item 6
Chunk 10
---
ExhibitNumber
      
     Description
     Form
     File No.
     Number
     Filing Date

     3.1
      
     Amended and Restated Certificate of Incorporation of the Registrant.
     8-K
     001-39539
     3.1
     September 29, 2020

     3.2
      
     Amended and Restated Bylaws of the Registrant.
     10-Q
     001-39539
     3.3
     May 10, 2023

     10.1+
      
     Amended Outside Director Compensation Policy.

     10.2+
      
     Offer Letter Agreement dated November 5, 2025, by and between the Registrant and Robert Ticktin.

     10.3+
      
     Amended and Restated Change in Control and Severance Policy Participation Agreement, dated November 5, 2025, by and between the Registrant and Robert Ticktin.

     31.1+
      
     Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

     31.2+
      
     Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

     32.1+†
      
     Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

     32.2+†
      
     Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

     101.INS
      
     Inline XBRL Instance Document-the Instance Document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.

     101.SCH
      
     Inline XBRL Taxonomy Extension Schema Document.

     104